Journal of Molecular Neuroscience

, Volume 19, Issue 1–2, pp 23–27

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial

  • Michael Grundman
  • Drahomira Sencakova
  • Clifford R. Jack
  • Ronald C. Petersen
  • Hyun T. Kim
  • Arlan Schultz
  • Myron F. Weiner
  • Charles DeCarli
  • Steven T. DeKosky
  • Christopher van Dyck
  • Ronald G. Thomas
  • Leon J. Thal
  • the Alzheimer’s Disease Cooperative Study
Early Detection Of Cognitive Impairment

Abstract

Mild Cognitive Impairment (MCI) is considered a transitional stage in the pathogenesis of Alzheimer’s disease; however, not all MCI patients progress to clinically defined AD or decline at identical rates. Hippocampal atrophy, as measured by Magnetic Resonance Imaging (MRI), may be a marker for hippocampal pathology in patients with MCI and predict a more rapid deterioration to clinical AD. In this study, we used MRI data from an ongoing MCI clinical trial to determine whether MRI hippocampal volume at baseline was associated with cognitive and functional performance in MCI subjects and whether it predicted those individuals who were more likely to develop AD. We performed correlational analyses between the MRI hippocampal volumes at study entry and the subjects’ concurrent performance on neuropsychological measures and clinical ratings. Larger hippocampal volume was associated with better performance on tests of memory, general cognition, and overall clinical ratings. Further analyses suggested that a smaller baseline hippocampal volume may be associated with a higher risk of developing clinical AD. As the trial is still ongoing, these results require confirmation once the trial is completed. In summary, these data suggest that MRI hippocampal volume may be a useful correlate of disease severity in MCI subjects and a prognostic indicator of subsequent AD.

Index Entries

Mild Cognitive Impairment Clinical trial MRI Hippocampal volume Alzheimer’s disease 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Folstein M. F., Folstein S. E., McHugh P. R. (1975) “Minimental state.” A practical method for grading the cognitive state of patients for the clinician. J. Psychiatric Res. 12, 189–198.CrossRefGoogle Scholar
  2. Grundman M., Petersen R. C., Morris J. C., et al. (1996) Rate of dementia of Alzheimer type (DAT) in subjects with mild cognitive impairment. The ADCS Cooperative Study. Neurology 46, A403.Google Scholar
  3. Jack C. R., Jr., Bentley M., Twomey C. K., and Zinsmeister A. R. (1990) MR-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology 176, 205–209.PubMedGoogle Scholar
  4. Jack C. R., Petersen R. C., Xu Y., et al. (2000) Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55, 484–489.PubMedGoogle Scholar
  5. Jack C. R., Jr., Petersen R. C., Xu Y. C., et al. (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397–1403.PubMedGoogle Scholar
  6. Jack C. R., Jr., Petersen R. C., Xu Y. C., et al. (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 49, 786–794.PubMedGoogle Scholar
  7. Morris J. C. (1997) Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int. Psychogeriatr. 9, 173–176; discussion 177–178.PubMedCrossRefGoogle Scholar
  8. Petersen R. C., Smith G. E., Ivnik R. J., et al. (1995) Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA 273, 1274–1278.PubMedCrossRefGoogle Scholar
  9. Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G., and Kokmen E. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303–308.PubMedCrossRefGoogle Scholar
  10. Rosen W. G., Mohs R. C., and Davis K. L. (1984) A new rating scale for Alzheimer’s disease. Am. J. Psychiatry 141, 1356–1364.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2002

Authors and Affiliations

  • Michael Grundman
    • 1
  • Drahomira Sencakova
    • 2
  • Clifford R. Jack
    • 2
  • Ronald C. Petersen
    • 2
  • Hyun T. Kim
    • 1
  • Arlan Schultz
    • 1
  • Myron F. Weiner
    • 3
  • Charles DeCarli
    • 4
  • Steven T. DeKosky
    • 5
  • Christopher van Dyck
    • 6
  • Ronald G. Thomas
    • 1
  • Leon J. Thal
    • 1
  • the Alzheimer’s Disease Cooperative Study
  1. 1.Department of NeurosciencesUniversity of CaliforniaSan Diego, La Jolla
  2. 2.Departments of Diagnostic Radiology, NeurologyMayo Clinic and FoundationRochester
  3. 3.Department of PsychiatryUniversity of Texas Southwestern Medical CenterDallas
  4. 4.Department of NeurologyUniversity of CaliforniaDavis
  5. 5.Department of NeurologyUniversity of PittsburghPittsburgh
  6. 6.Department of PsychiatryYale University School of MedicineNew Haven
  7. 7.Alzheimer’s Disease Cooperative StudyLa Jolla

Personalised recommendations